for SREBP-1 activation (Okazaki et al., 2010; Xu et al., 2010).
The Parkinson's disease proteins PINK1 and Parkin are proposed guardians of mitochondrial fidelity, targeting damaged mitochondria for degradation by mitophagy. In this issue of Cell, Wang et al. (2011) now show that PINK1 and Parkin also regulate mitochondrial trafficking and quarantine damaged mitochondria by severing their connection to the microtubule network.
To maintain the mitochondrial network in good working order, mitochondria undergo continuous cycles of fission and fusion, promoting the redistribution of refurbished contents throughout the system. Sometimes, however, mitochondria can become too badly damaged to be rescued by this cycle and must be culled from the network. We now understand that these damaged organelles can be recycled by a form of mitochondrial autophagy known as mitophagy. Two proteins known to be mutated in certain forms of early onset Parkinson's disease, the E3 ubiquitin ligase Parkin and the serine/threonine kinase PINK1, mediate mitophagy following mitochondrial damage and target specific substrates for proteasomal degradation (Deas et al., 2011; Kawajiri et al., 2011) . In this issue of Cell, Wang et al. (2011) identify the mitochondrial outer-membrane protein Miro as a substrate of PINK1 and show that it is degraded through a Parkin-dependent mechanism. Destruction of Miro unhooks damaged mitochondria from the microtubule network, preventing their transport throughout the cell.
Previous studies have shown that the PINK1/Parkin mitochondrial surveillance pathway is activated when degradation of PINK1 is inhibited, leading to an increase in the abundance of PINK1 on the mitochondrial outer membrane. This increase results in the recruitment of Parkin to mitochondria by a kinase-dependent mechanism. Once present on mitochondria, Parkin ubiquitinates a subset of protein targets, leading to their proteasomal degradation and ultimately the destruction of the entire damaged organelle via mitophagy ( Figure 1 ). As PINK1 and Parkin mutations are linked to neurodegeneration in Parkinson's disease, the study by Wang et al. adds the important finding that Parkin is recruited to damaged mitochondria not only in cultured cell lines (Narendra et al., 2008) , but also in primary neurons. Now, Miro has been identified as a PINK1 substrate. Miro is a Rho-like GTPase that plays an important role in the movement of mitochondria within cells. It is anchored by a single C-terminal transmembrane domain in the outer mitochondrial membrane and has two GTPase domains and two EF hands that face the cytosol and are critical for Miro function (Fransson et al., 2003; Frederick et al., 2004) . The protein connects mitochondria to microtubules via its binding partners Milton and kinesin heavy chain (KHC) and is required for mitochondrial transport. Neuronal cells in particular depend on efficient trafficking of mitochondria to supply distant subcellular locations between the cell body and the axon terminal, and defects in this process are associated with neuron dysfunction (Guo et al., 2005) .
The study in this issue by Wang et al. made the initial observation that overexpression of PINK1 or Parkin in cultured mouse or fly neurons results in arrest of mitochondrial motion. Because the Miro/Milton/KHC complex is the most characterized pathway involved in mitochondrial movement and Miro and its partner Milton can bind to PINK1 (Weihofen et al., 2009) , the authors studied the connection between Miro and the PINK1/Parkin pathway. They found that Miro can be directly phosphorylated by PINK1 and that, upon damage to mitochondria, Miro is degraded in a Parkin-dependent manner. The authors also identify a PINK1/Parkin/Miro complex (Figure 1 ). This suggests that Miro is a substrate and binding partner of both PINK1 and Parkin. The final outcome of the modification and degradation of Miro is the arrest and segregation of damaged mitochondria prior to their degradation by mitophagy, thus protecting the healthy mitochondrial network.
Along with its role in mitochondrial trafficking, Miro (and its yeast homolog Gem1p) has now been localized to mitochondria-ER contact sites (Kornmann et al., 2011) . These structures play multifaceted roles in the maintenance of the lipid bilayers of both organelles and are important locations for calcium release and signaling. One might speculate that, in addition to halting mitochondrial traffic, Miro degradation by the PINK1/Parkin pathway may also free the ER from mitochondrial tethers. This secondary role might protect the ER from damaged mitochondria, and the loss of ER contacts may facilitate mitophagy.
Because Parkin and PINK1 were first implicated in mitophagy, there have been many models to explain precisely what their role is in this process. However, there is little consensus on how PINK1 recruits Parkin or how Parkin-tagged mitochondria are recognized by autophagosomes. One hypothesis is that Parkin recruitment is a result of direct phosphorylation and/or binding by PINK1. It has also been suggested that these two enzymes may have shared substrates and that phosphorylation of these substrates by PINK1 leads to the recruitment of Parkin. The discovery that Miro is bound by PINK1 and Parkin and is likely a substrate of both adds weight to the latter ''shared substrate'' hypothesis. Given the number of Parkin substrates on the mitochondrial outer membrane, it is unlikely that Miro is unique in this respect. The study by Wang et al. not only reveals a glimpse into how PINK1 and Parkin cooperate, but also shows that mitochondrial quality control systems can directly alter mitochondrial transport and raises the possibility that one aspect of Parkinson's disease is the inappropriate trafficking of damaged mitochondria. 
